Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active immunisation against human tick-borne diseases.

Simona Bratu1, Larry I Lutwick

  • 1Infectious Diseases (IIIE), VA NY Harbor Healthcare System, 800 Poly Place, Brooklyn, New York 11209, USA.

Expert Opinion on Biological Therapy
|February 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of Inpatient Admission for Mpox Infection Control Isolation at 2 Large New York City Health Systems, 2022-2023.

Public health reports (Washington, D.C. : 1974)·2025
Same author

Preventing central line-associated bloodstream infections: A position paper of the International Society for Infectious Diseases, 2024 update.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2024
Same author

HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak.

AIDS patient care and STDs·2021
Same author

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model.

Mayo Clinic proceedings·2021
Same author

Rise and fall of KPC-producing Klebsiella pneumoniae in New York City.

The Journal of antimicrobial chemotherapy·2016
Same author

Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.

The Journal of antimicrobial chemotherapy·2012
Same journal

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
See all related articles

New vaccines for tick-borne diseases like Lyme borreliosis are emerging. This review covers vaccines for Lyme borreliosis, tick-borne encephalitis, and other tick-borne infections, plus anti-tick immunization strategies.

Area of Science:

  • Veterinary Medicine
  • Infectious Diseases
  • Vaccinology

Background:

  • The recent development of a recombinant vaccine for Lyme disease has increased interest in vaccines for other tick-borne infections.
  • Tick-borne diseases pose significant threats to both human and animal health globally.
  • Existing vaccines and ongoing research for various tick-borne illnesses warrant a comprehensive overview.

Purpose of the Study:

  • To review available and developing vaccine information for a range of tick-borne infections.
  • To discuss the potential of anti-tick immunization as a method to reduce disease transmission.
  • To provide a consolidated resource for researchers and public health officials in the field of tick-borne disease prevention.

Main Methods:

  • Literature review of published studies and clinical trial data on vaccines for tick-borne diseases.

Related Experiment Videos

  • Inclusion of information on vaccines targeting specific pathogens (e.g., Borrelia burgdorferi, tick-borne encephalitis virus).
  • Examination of research concerning vaccines that target the tick vector itself.

    • Main Results:

    • Vaccine information is presented for Lyme borreliosis, tick-borne encephalitis (TBE), Rocky Mountain spotted fever, tularaemia, Query (Q) fever, and Kyasanur Forest disease (KFD).
    • The review also addresses vaccines for tick paralysis.
    • Immunization strategies targeting ticks may reduce both veterinary tick burdens and disease transmission.

    Conclusions:

    • A growing portfolio of vaccines is becoming available for tick-borne infections, offering new prevention avenues.
    • Anti-tick immunization presents a promising complementary strategy for controlling tick-borne diseases.
    • Further research and development in vaccinology are crucial for combating the global burden of tick-borne illnesses.